Our detection of this Orai3 mechanism in endothelial cells from patients with coronary artery disease and cancer suggests relevance in pathophysiological settings; in support of this, atherosclerosis, tissue injury, cancer, and other related conditions have all been associated with increased PLA2 activity and AA.39–42. This evidence concerns the gene ORAI3 and cancer.